- Home
- NAAS vs HSCS Comparison
NAAS vs HSCS Comparison
Compare NAAS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- HSCS
- Stock Information
- Founded
- NAAS 2019
- HSCS 2007
- Country
- NAAS China
- HSCS United States
- Employees
- NAAS N/A
- HSCS N/A
- Industry
- NAAS Other Specialty Stores
- HSCS Medical Specialities
- Sector
- NAAS Consumer Discretionary
- HSCS Health Care
- Exchange
- NAAS Nasdaq
- HSCS Nasdaq
- Market Cap
- NAAS 9.0M
- HSCS 9.9M
- IPO Year
- NAAS 2017
- HSCS 2022
- Fundamental
- Price
- NAAS $3.50
- HSCS $3.16
- Analyst Decision
- NAAS
- HSCS Strong Buy
- Analyst Count
- NAAS 0
- HSCS 2
- Target Price
- NAAS N/A
- HSCS $10.50
- AVG Volume (30 Days)
- NAAS 59.0K
- HSCS 25.5K
- Earning Date
- NAAS 11-19-2025
- HSCS 12-15-2025
- Dividend Yield
- NAAS N/A
- HSCS N/A
- EPS Growth
- NAAS N/A
- HSCS N/A
- EPS
- NAAS N/A
- HSCS N/A
- Revenue
- NAAS $21,817,052.00
- HSCS $6,250.00
- Revenue This Year
- NAAS $378.49
- HSCS N/A
- Revenue Next Year
- NAAS N/A
- HSCS N/A
- P/E Ratio
- NAAS N/A
- HSCS N/A
- Revenue Growth
- NAAS N/A
- HSCS N/A
- 52 Week Low
- NAAS $1.96
- HSCS $2.52
- 52 Week High
- NAAS $55.84
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- NAAS 49.63
- HSCS 36.80
- Support Level
- NAAS $3.40
- HSCS $3.16
- Resistance Level
- NAAS $3.72
- HSCS $3.43
- Average True Range (ATR)
- NAAS 0.35
- HSCS 0.16
- MACD
- NAAS -0.04
- HSCS -0.04
- Stochastic Oscillator
- NAAS 44.78
- HSCS 1.67
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.